Market Place
Sourcing Support
Rigel Inks $162.5M Oncology Deal With Kissei For Asian Markets
05 Sep 2024 //
BIOSPECTRUM ASIA
CG Oncology Begins Dosing in Japan in Phase 3 Monotherapy Study of CG0070
20 Dec 2021 //
BUSINESSWIRE
VFMCRP announces approval for TAVNEOS for ANCA-associated vasculitis in Japan
27 Sep 2021 //
BUSINESSWIRE
Licensing Agreement for GnRH Antagonist Linzagolix with Bio Genuine in China
02 Sep 2021 //
KISSEI
Launch of UPASITA for the Treatment of Secondary Hyperparathyroidism
19 Aug 2021 //
PRESS RELEASE
Licensing Agreement with Affamed for KDT-3594, a Novel Investigational Drug
09 Oct 2020 //
PRESSRELEASE
Rigel`s fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharma
23 Sep 2019 //
PR NEWSWIRE
Sanofi, Eisai join Lilly`s SCOTUS bid to save Cialis from patent claims
09 Jul 2019 //
FIERCE PHARMA
Imbruvica (ibrutinib): Pharmacyclics, Janssen Biotech vs. Hetero Labs
24 Nov 2018 //
PATENT LITIGATION
Velcade (Bortezomib): Millennium Pharmaceuticals vs Hetero Labs Limited
24 Nov 2018 //
PATENT LITIGATION
Kyorin Receives Marketing Approval in Japan for "Beova® Tablets 50mg" for OAB
21 Sep 2018 //
PRESS RELEASE
Kissei To Market Avacopan In Japan For Vifor Fresenius Medical Care Renal Pharma
08 Jun 2017 //
GLOBENEWSWIRE
Kissei gives up on dry eye drug
25 Apr 2017 //
THE PHARMALETTER
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.